A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
This study has been completed.
Information provided by (Responsible Party):
Carrie Cwiak, Emory University
First received: November 14, 2005
Last updated: August 10, 2013
Last verified: August 2013
This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.
||Observational Model: Cohort
Time Perspective: Prospective
||A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods (Oral Contraceptive Pills, Depo Provera and Ortho Evra) Among Women Seeking First Trimester Abortion.
Primary Outcome Measures:
| Study Start Date:
| Study Completion Date:
| Primary Completion Date:
||November 2005 (Final data collection date for primary outcome measure)
Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor compliance with contraceptive methods and results in unintended pregnancies. This study will evaluate the 3-month continuation rates among women using the oral contraceptive pill and Depo-Provera. It will also assess the continuation rates of Ortho Evra®, which has not previously been studied in the adolescent population. This study will provide information with regard to pregnancy rates and 3-month patterns of use of contraception among women seeking first-trimester abortion. It will also assess other factors contributing to successful contraception such as the use of emergency contraception and concomitant condom use. The results of this study will be used to inform the practice of providers who provide reproductive health care to women and add to the sparse body of literature available comparing the success of different contraceptive methods used by women.
|Ages Eligible for Study:
||13 Years to 45 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Participants were recruited from a indigent, urban, African American population.
- Age 13-45 women presenting at the ambulatory surgery at Grady Memorial Hospital who want to use either oral contraceptive pills, ortho evra or depo provera?
- Leaving the Atlanta area within 6 months?
- Desires pregnancy within the next 6 months?
- Unable to provide contact information?
- Contraindications to hormonal contraceptive?
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00253019
|Grady Memorial Hospital
|Atlanta, Georgia, United States, 30303 |
||Carrie Cwiak, MD, MPH
No publications provided
||Carrie Cwiak, Principal Investigator, Emory University
History of Changes
|Other Study ID Numbers:
|Study First Received:
||November 14, 2005
|Results First Received:
||April 9, 2013
||August 10, 2013
||United States: Institutional Review Board
Keywords provided by Emory University:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on April 16, 2015
Physiological Effects of Drugs
Reproductive Control Agents